Trial intelligence / Profile preview

PCV-13 Experimental Human Pneumococcal Carriage Study

2012-005141-20Phase 4Completed

Sponsor
Royal Liverpool University Hospital
Start
Feb 2013
Modality
Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of pneumococcal 13-valent conjugate vaccine, Hepatitis A virus vaccine in pneumococcal disease, sponsored by Royal Liverpool University Hospital. Started Feb 2013; status: completed.

02

Drugs

pneumococcal 13-valent conjugate vaccineHepatitis A virus vaccine
03

Conditions

pneumococcal disease

Beyond the preview

Go deeper on 2012-005141-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005141-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call